The international system Covax, which provides vaccines against covid-19 to poor countries, said on Wednesday (19) that it needs 5.2 billion dollars in three months to finance doses of the immunizer in 2022.
Covax celebrated this weekend the overcoming of the milestone of 1 billion doses offered, after a year of operations and the acceleration of vaccination in November and December 2021.
read more:
“In 2022, we can help contain Covid by adapting the way we act and ensuring doses are used quickly, safely injected, and respond to country preferences and coverage goals,” said Seth Berkley, head of the Vaccine Alliance. , one of Covax’s pillars with WHO, Unicef and Cepi.
“This will help the world to reduce the risks of the pandemic and uncertainties”, he highlighted, on the occasion of a call to donors.
Covax needs $3.7 billion to fund a reserve of 600 million doses. The reserve must guarantee that the supply is carried out without problems and thus be able to face unforeseen events such as booster doses adapted to the new variants.
Another $1 billion will go to help low-income countries prepare and distribute vaccines to avoid waste.
In addition, US$545 million will be used to cover costs such as transport, syringes and insurance.
To date, Covax has received $192 million from donors.
WHO chief Tedros Adhanom Ghebreyesus once again denounced the lack of equity in terms of vaccines, pointing out that although 10 billion doses of anti-covid have been administered so far, about half of the world’s population has not yet been vaccinated.
The international system Covax, which provides vaccines against covid-19 to poor countries, said on Wednesday (19) that it needs 5.2 billion dollars in three months to finance doses of the immunizer in 2022.
Covax celebrated this weekend the overcoming of the milestone of 1 billion doses offered, after a year of operations and the acceleration of vaccination in November and December 2021.
read more:
“In 2022, we can help contain Covid by adapting the way we act and ensuring doses are used quickly, safely injected, and respond to country preferences and coverage goals,” said Seth Berkley, head of the Vaccine Alliance. , one of Covax’s pillars with WHO, Unicef and Cepi.
“This will help the world to reduce the risks of the pandemic and uncertainties”, he highlighted, on the occasion of a call to donors.
Covax needs $3.7 billion to fund a reserve of 600 million doses. The reserve must guarantee that the supply is carried out without problems and thus be able to face unforeseen events such as booster doses adapted to the new variants.
Another $1 billion will go to help low-income countries prepare and distribute vaccines to avoid waste.
In addition, US$545 million will be used to cover costs such as transport, syringes and insurance.
To date, Covax has received $192 million from donors.
WHO chief Tedros Adhanom Ghebreyesus once again denounced the lack of equity in terms of vaccines, pointing out that although 10 billion doses of anti-covid have been administered so far, about half of the world’s population has not yet been vaccinated.
